Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.
about
Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Deferasirox, a novel oral iron ...... c cancer in vitro and in vivo.
@ast
Deferasirox, a novel oral iron ...... c cancer in vitro and in vivo.
@en
type
label
Deferasirox, a novel oral iron ...... c cancer in vitro and in vivo.
@ast
Deferasirox, a novel oral iron ...... c cancer in vitro and in vivo.
@en
prefLabel
Deferasirox, a novel oral iron ...... c cancer in vitro and in vivo.
@ast
Deferasirox, a novel oral iron ...... c cancer in vitro and in vivo.
@en
P2093
P2860
P1433
P1476
Deferasirox, a novel oral iron ...... c cancer in vitro and in vivo.
@en
P2093
Hirofumi Harima
Isao Sakaida
Koichi Fujisawa
Naoki Yamamoto
Seiji Kaino
Shuhei Shinoda
Takahiro Yamasaki
Taro Takami
Toshihiko Matsumoto
P2860
P2888
P356
10.1186/S12885-016-2744-9
P407
P577
2016-08-31T00:00:00Z
P6179
1015122930